Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01196117 · ClinicalTrials.gov registry record · NA

Sleepiness and the Effects of CPAP on Salivary Cortisol and Alpha-Amylase Levels in Patients With Sleep Apnea

A NA study of Sleep Apnea and Sleep Disordered Breathing, sponsored by Medical College of Wisconsin.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT01196117 is a NA study of Sleep Apnea and Sleep Disordered Breathing that has completed, run by Medical College of Wisconsin. The registered enrollment target is 18 participants, below the 2,989-participant average among 36 other Sleep Apnea trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01196117, a NA study of Sleep Apnea and Sleep Disordered Breathing, has completed, sponsored by Medical College of Wisconsin.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

Patients with Obstructive Sleep Apnea Syndrome (OSAS) will evidence higher levels of salivary cortisol and alpha-amylase levels prior to use of placebo and continuous positive airway pressure (CPAP) and will evidence a decrease in these levels after consistent use of continuous positive airway pressure (CPAP) therapy as compared to placebo. Their level of sleepiness will also decrease with the use of CPAP therapy and will correlate with the levels of salivary cortisol and alpha-amylase in relation to their subjective sleepiness scale, Psychomotor Vigilance Test (PVT), and pupillometry.

Conditions Studied

Sleep Apnea Sleep Disordered Breathing

Interventions

  • DEVICE 14 days of placebo therapy
  • DEVICE 14 days of CPAP therapy

Study Locations (1)

Wisconsin

  • Froedtert West Clinics - Otolaryngology Clinc - Milwaukee

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2004-11-15
Est. Completion 2011-12-15
Phase NA

Sponsor

Medical College of Wisconsin

447 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01196117

The ClinicalTrials.gov registry entry for NCT01196117 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,989-participant average among 36 other Sleep Apnea trials with a reported enrollment target (99% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which 14 days of placebo therapy is the first listed.

NCT01196117 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT01196117 about?

NCT01196117 is a clinical study titled "Sleepiness and the Effects of CPAP on Salivary Cortisol and Alpha-Amylase Levels in Patients With Sleep Apnea". Patients with Obstructive Sleep Apnea Syndrome (OSAS) will evidence higher levels of salivary cortisol and alpha-amylase levels prior to use of placebo and continuous positive airway pressure (CPAP) and will evidence a decrease in these levels after consistent use of continuous positive airway press...

What is the current status of trial NCT01196117?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2004-11-15. Estimated completion is 2011-12-15.

What conditions does trial NCT01196117 study?

This clinical trial studies the following conditions: Sleep Apnea, Sleep Disordered Breathing.

What interventions are being tested in trial NCT01196117?

The interventions under investigation include: 14 days of placebo therapy (DEVICE), 14 days of CPAP therapy (DEVICE).

Who is sponsoring clinical trial NCT01196117?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01196117 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sleep Apnea

All registered trials for this condition

Sleep Disordered Breathing

All registered trials for this condition

Wisconsin

All trials with a study site in Wisconsin

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.